Pfizer receive FDA acceptance for OXECTA Tablets to control severe pain Pfizer Inc.

‘Acura is targeted on developing technologies that are intended to potentially deter misuse and misuse.’.. Acura, Pfizer receive FDA acceptance for OXECTA Tablets to control severe pain Pfizer Inc. and Acura Pharmaceuticals Inc. announce the marketing acceptance from the U.S. Food and Medication Administration of OXECTATM Tablets CII. OXECTA is indicated for the management of acute and chronic moderate to severe pain where the usage of an opioid analgesic is suitable.Leon received his MD and PhD from Autonomy University, Madrid , and his PhD work was focused on the diagnosis and pathogenesis of Celiac disease. A residency was finished by him in Clinical Immunology at Ramon y Cajal Hospital, Madrid where he was elected Resident of the entire year in Spain in 2001 . Dr. Leon was a postdoctoral fellow in the Laboratory of Clinical Investigation and in the Laboratory of Molecular Immunology of the National Institutes of Allergy and Infectious Diseases, National Institutes of Wellness.